About Index Trending news
Analyze
Pricing
Spero Therapeutics

Spero Therapeutics

Work at Spero Therapeutics? Add yourself to this profile

Spero Therapeutics

Developing novel therapeutics for drug-resistant bacterial infections

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series C)
$51,700,000
RA Capital Management, Rock Springs Capital, GV
Venture capital (Series B)
$30,000,000
Atlas Venture, SR One, Partners Innovation Fund, +3
Employees

Team size

2
Locations
HQ
$51,700,000 Venture capital (Series C)
Spero Therapeutics

Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing

Xconomy

Google’s Venture Arm Leads $51.7M Investment in Spero Therapeutics

Funding Health
Xconomy

Spero Rolls up More Antibiotics With Vertex Deal

Health
Xconomy

Spero Eyes First Trial, Gets $30M More to Battle Drug-Resistant Bugs

Health Funding
$30,000,000 Venture capital (Series B)
FinSMEs

Spero Therapeutics Raised $30M in Series B Funding

Health Funding